Apigenin has neuroprotective effects in a mouse model of AD (APP/PS1 double transgenic mice), where it improves memory and learning deficits, and reduces fibrillar amyloid deposits by restoring activity of the ERK/CREB/BDNF pathway [111]. Here, APP is linked to Alzheimer disease.